Overview


According to FutureWise analysis the market for Postoperative Pain Management is expected to register a CAGR of 6.00% from 2023-2031.

Postoperative pain is a complex reaction to tissue stress following surgical treatments. It includes both pains from surgery and pain associated with central nervous system sensitivity. Postoperative pain management drugs aim to reduce or eliminate side effects while minimizing pain and discomfort. Treatment of the triggering cause and analgesic drugs frequently relieve such discomfort. Also, postoperative pain might affect an individual's heart, lungs, endocrine system, metabolism, etc. Any postoperative pain management strategy should attempt to get the patient moving immediately. It enables the patient to eat and drink promptly, as well as to cough and take deep breaths. Patients risk developing heart issues, chest infections, depression, wounds with higher infection rates, and hypoxia if effective postoperative pain management is not provided. Postoperative pain management has developed with new knowledge of the interactions between medications and their effects on the body. In terms of value, opioids and non-steroidal anti-inflammatory medicines are anticipated to account for a significant portion of the postoperative pain market.

Because of the rise in surgical operations and the severity of postoperative pain, the global market for postoperative pain therapies is anticipated to expand during the forecast period. The creation of various novel drugs is expected to increase the market for postoperative pain management worldwide. The development of new medication uses broad safety margins and beneficial properties. The significance of non-opioid adjuncts and alternatives has grown for the treatment of postoperative pain. Non-steroidal anti-inflammatory drugs (NSAIDs), intravenous (IV) acetaminophen, magnesium, and ketamine are a few examples of drugs that have been well-liked in the postoperative pain market. Postoperative pain therapies have thus taken over in both emerging and developed markets due to cutting-edge medications, increasing demand, easier access, and superior pain management.

FutureWise Market Research has published a report that provides an insightful analysis of postoperative pain management market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the postoperative pain management market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • Teva Pharmaceutical Industries Ltd.
  • Egalet Corporation
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Allergan plc.
  • Mylan N.V.
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Janssen Pharmaceuticals, Inc.
  • Endo International plc.
  • Pacira Pharmaceuticals Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Postoperative Pain Management Market:

In March 2022- The perioperative long-acting analgesic medicine CPL-01 underwent a successful Phase IIb study, according to Cali Biosciences Co., Ltd., a biopharmaceutical company specializing in the innovation and development of novel medications.

Due to variables, including the prevalence of chronic disease, the rise in surgical procedures, the desire for novel non-opioid analgesics in postoperative pain management therapy, and the growing awareness of palliative care, postoperative pain management approaches are becoming more and more necessary. Expanding consumer demand for painkillers is a key factor in industry growth. The increasing number of procedures being conducted worldwide is mostly accountable for the excessive use of painkillers. Rising traffic accidents, relative trauma injuries, and postoperative pain management are projected to boost market demand. Moreover, the market for postoperative pain management is predicted to grow internationally due to the development of numerous novel medications. New medications are being created that have broad safety margins and advantageous qualities. Non-opioid adjuncts and alternatives for the treatment of postoperative pain are now more important than ever. NSAIDs, magnesium, ketamine, dexmedetomidine, and liposomal bupivacaine are some medications popular on the market for treating postoperative pain. Due to new drugs, rising demand, and improved pain treatment, postoperative pain medications are expected to become standard in emerging and developed markets. However, the unpleasant side effects associated with excessive NSAID and opioid use, as well as the shortage of easily accessible postoperative pain treatments, are factors that are restricting the market. For instance, long-term morphine use may cause serious harm to the body's immune system, which can result in physical and mental addiction. In developed nations, the use of opioid prescriptions has decreased as a result of rising drug addiction rates and the addictive properties of opioids. The subsequent decline in opioid consumption has further hampered market expansion.

By Drug Class

  • Opioids
  • NSAIDS
  • Local Anaesthetics
  • Acetaminophen

By Route of Administration

  • Injectable
  • Oral
  • Topical
  • Transdermal
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Drug store
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. It is expected that the adoption of opioid treatment will slow the opioid epidemic's spread across North America, especially in the United States. Additionally, a robust drug pipeline with effective drugs awaiting FDA approval in this region is expected to increase the use of postoperative pain medications. In the United States, patients' views have changed as a result of better adherence to advice for pain medication. These statistics will likely increase the region's need for postoperative pain management medications, supporting industry growth. Additionally based on drug class; opioids hold largest market share in 2022.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Postoperative Pain Management Market By Drug Class, By Route of Administration, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Postoperative Pain Management Market Variables, Trends and Scope

    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Postoperative Pain Management Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Postoperative Pain Management Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Postoperative Pain Management Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Opioids
        2. NSAIDS
        3. Local Anaesthetics
        4. Acetaminophen

  • 8.   Postoperative Pain Management Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Injectable
        2. Oral
        3. Topical
        4. Transdermal
        5. Others

  • 9.   Postoperative Pain Management Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital pharmacies
        2. Retail pharmacies
        3. Drug store
        4. Clinics
        5. Others

  • 10.   North America Postoperative Pain Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Postoperative Pain Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Postoperative Pain Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Postoperative Pain Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Teva Pharmaceutical Industries Ltd.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Egalet Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. GlaxoSmithKline Plc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Novartis AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Allergan plc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Mylan N.V.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Pfizer Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Purdue Pharma L.P.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Janssen Pharmaceuticals, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Endo International plc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Pacira Pharmaceuticals Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11